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Abstract 
Background: Recent findings indicated that a correlation between genomic % AT and genome size within strains 
of microbial species was predominantly associated with the uptake of foreign DNA. One species however, Chlamydia 
trachomatis, defied any explanation. In the present study 79 fully sequenced C. trachomatis genomes, representing 
ocular- (nine strains), urogenital- (36 strains) and lymphogranuloma venereum strains (LGV, 22 strains), in three patho-
groups, in addition to 12 laboratory isolates, were scrutinized with the intent of elucidating the positive correlation 
between genomic AT content and genome size.
Results: The average size difference between the strains of each pathogroup was largely explained by the incorpora-
tion of genetic fragments. These fragments were slightly more AT rich than their corresponding host genomes, but 
not enough to justify the difference in AT content between the strains of the smaller genomes lacking the fragments. 
In addition, a genetic region predominantly found in the ocular strains, which had the largest genomes, was on aver-
age more GC rich than the host genomes of the urogenital strains (58.64 % AT vs. 58.69 % AT), which had the second 
largest genomes, implying that the foreign genetic regions cannot alone explain the association between genome 
size and AT content in C. trachomatis. 23,492 SNPs were identified for all 79 genomes, and although the SNPs were on 
average slightly GC rich (~47 % AT), a significant association was found between genome-wide SNP AT content, for 
each pathogroup, and genome size (p < 0.001, R2 = 0.86) in the C. trachomatis strains.
Conclusions: The correlation between genome size and AT content, with respect to the C. trachomatis pathogroups, 
was explained by the incorporation of genetic fragments unique to the ocular and/or urogenital strains into the LGV- 
and urogential strains in addition to the genome-wide SNP AT content differences between the three pathogroups.
© 2015 Bohlin. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided 
you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate 
if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/
zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Several studies have described the evolutionary process 
of genome reduction in which microbes undergo genome 
degradation as they become attached to a host, either in a 
parasitic or a mutualistic relationship [1]. The genomes of 
these microbes tend to be marked by dysfunctional DNA 
maintenance proteins and genetic drift which in turn lead 
to accumulated mutations in genes that are not impor-
tant for the microbe’s existence [2]. Superfluous genes 
are eventually lost, since there appears to be an evolu-
tionary drive in the direction of genome minimization 
[3]. Although exceptions exists [1], the genomes of these 
symbionts/mutualists are to a large extent AT-rich due 
to the mutational bias towards AT-richness [4]. A nega-
tive correlation has been found between genomic AT 
content and genome size in some prokaryotic phyla [5, 6] 
(i.e. genome size decrease with increasing AT content). 
However, it was recently shown that for strains within 
several microbial species there was a positive correlation 
between genomic AT content and genome size [7]. This 
correlation was linked to horizontal gene transfer (HGT), 
DNA uptake and/or recombination of AT rich sequences 
[7], but the species Chlamydia trachomatis seemed to 
be an exception since it could not be shown that foreign 
DNA had been integrated into the genomes of any of the 
sequenced strains [7].
Chlamydia trachomatis is a Gram-negative, obli-
gate intracellular pathogen leading a parasitic lifestyle 
presumably only in humans [8]. Of the sequenced and 
assembled strains, the species’ AT content ranges from 
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58.5 to 58.7  % and the genome size from 1,038,310 to 
1,083,890  bp. (See Additional file  1 for details). C. tra-
chomatis has been divided into three distinct lineages, or 
pathogroups, based on serovars; one associated with tra-
choma (serovars A–C) another with urogenital infections 
(serovars D–K) and the third with lymphogranuloma 
venereum (LGV) and proctitis (serovars L1–L3) [8].
Although C. trachomatis is presumed to affect humans 
only, other animals may be infected by different species 
of Chlamydia. Since the focus of interest here is genome 
expansion in C. trachomatis the reader is referred else-
where for more information concerning other species of 
Chlamydia [8, 9].
Hence, the aims of the study were to scrutinize the pos-
itive association between AT content and genome size 
in C. trachomatis to shed more light on the evolutionary 
processes involved.
Results
Exploration of the different pathogroups
Since C. trachomatis taxonomy is complicated by the 
discovery that substantial parts of the outer membrane 
gene (ompA), much used for taxonomic assessment of 
C. trachomatis strains into different serovars, has often 
undergone HGT with other C. trachomatis strains [10], 
additional tests to assess C. trachomatis phylogeny were 
carried out. This included genome-wide single nucleo-
tide polymorphism (SNP) based phylogenetic analysis in 
addition to a hierarchical cluster analysis based on whole-
genome trinucleotide frequencies normalized by the 
respective nucleotide frequencies (trinucleotide zero’th 
order Markov model) on 79 C. trachomatis genomes [11]. 
A lot can also be said about C. trachomatis phylogeny 
by scrutinizing the different strains corresponding plas-
mids, but since the focus of the present work is genome 
expansion with respect to the main chromosome the 
interested reader is referred to the article by Harris et al. 
which gives a thorough account on the subject [12]. From 
both Figs.  1, 2, respectively describing the SNP based- 
and hierarchical cluster analysis, it can be seen that the 
pathogroups cluster perfectly together (the yellow labo-
ratory isolates are C. trachomatis isolates from the three 
pathogroups artificially manipulated in the laboratory) 
indicating that the serovars associated with each patho-
group are subjected to similar selective pressures [2, 13]. 
Four of the included recombinant laboratory isolates 
contained a genome island (GI) with antibiotic resistance 
genes also identified in the pig pathogen C. suis [14, 15]. 
Both Figs. 1, 2 show that there is a slight division within 
the urogenital strains (colored green), which is also sup-
ported by previous work [12, 16]. While pattern differ-
ences from trinucleotide frequencies can be observed in 
Fig. 2, the SNP-based phylogenetic tree in Fig. 1 suggests 
a greater division amongst primarily the E and F sero-
vars (including C. trachomatis D SotonD1 and D 13 96 
strains) of the urogenital strains and the D, G, I, J and K 
serovars, which are closer to the trachoma strains of the 
A–C serovars than the E and F serovars.
Genome size, base composition and mutational bias
Figure  3 demonstrates a positive correlation between 
genome size and AT content in the C. trachomatis strains 
(average genome size and AT content for all patho-
groups and laboratory isolates can be found in Table 1), 
and that this association is linked to the different patho-
groups (p  <  0.001). Within the pathogroups, however, 
no such association was found (p ~ 0.54, p ~ 0.74 for the 
urogenital- and LGV pathogroups containing 36 and 22 
strains, respectively) with the exception of the strains in 
the pathogroup linked with trachoma (p  <  0.001). The 
trachoma pathogroup however consisted of nine strains 
only and the result must therefore be considered as pre-
liminary at the moment and will not be further discussed 
here.
The genetic regions unique to each pathogroup have 
been described previously [17], and a detailed visualiza-
tion can be observed from the ACT-comparison [18] in 
Fig.  4 between the trachoma strain C. trachomatis A/
HAR 13 (NC 007429.1) the urogenital strain C. tra-
chomatis D/UW-3/CX (NC 000117.1) and the LGV strain 
C. trachomatis L2b UCH1 (NC 010280.2). The genes par-
ticular to each pathogroup are shown in Table 2. Table 3 
describes the average AT content and the size of these 
genetic regions unique to each pathogroup. It can be 
seen from Table  3 that the genomic fragments unique 
to both serovars A–C and D–K, and not found within 
the LGV clade, are more AT rich than the LGV strains 
on average (see Table  1). Moreover, the genetic frag-
ments predominantly found within serovars A–C are, in 
fact, slightly more GC rich than the urogenital strains on 
average, as well as the strains in serovar A–C, implying 
that the incorporation of these genetic fragment into the 
urogenital strain would not explain the AT content differ-
ence between the urogenital and ocular pathogroups (see 
Table 4). Furthermore, Table 4 indicates that the average 
AT content and the size of the genomic fragments from 
the different serovars can, in general, not fully explain the 
AT content differences between the three pathogroups. 
To elucidate this conundrum further mutational biases 
were analyzed from the genome-wide SNP analyses of 
which the phylogenetic tree in Fig.  1 is based on. The 
SNP-based phylogenetic tree demonstrates that there are 
differences with regards to mutational biases, and that 
these correspond well with the established pathogroups 
[12]. Moreover, Fig. 5 demonstrates that SNP AT content 
differs significantly between the pathogroups (p < 0.001), 
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Fig. 1 SNP-based phylogenetic tree. The figure shows a phylogenetic tree, rooted by the lymphogranuloma venereum (LGV)-strains, which presum-
ably are most similar to the last common ancestor of the 79 C. trachomatis genomes depicted. The strains are divided into two biovars: the LGV- and 
urogenital strains. The urogenital strains are further split into two lineages T1 and T2. The T2 lineage is again split into the urogenital- and ocular 
strains
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with the possible exception of the laboratory isolates, 
although varying substantially in size have SNPs and AT 
content more similar to the strains from the pathogroups 
they were originally chosen from (p ~ 0.05 to p ~ 0.002 
with the LGV and urogenital pathogroups, respectively) 
[14]. Nevertheless, as can be seen from Fig. 5, the aver-
age SNP AT content is highest for the trachoma strains, 
second highest for the urogenital strains and lowest for 
the LGV strains, which also correspond with the aver-
age genome size of each pathogroup (of course, with the 
exception of the artificially manipulated laboratory iso-
lates). Figure  6 demonstrates that a strong association 
between genome size and SNP AT content was observed 
(p  <  0.001, R2  =  0.86), although this association is not 
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Fig. 2 Genome-based taxonomic assessment of C. trachomatis strains. The heatmap shows a two-way hierarchical cluster analysis performed on 
the estimated zero’th order Markov model based trinucleotide frequencies in 79 C. trachomatis genomes. The leftmost colored column indicates 
pathogroup: red trachoma (A–C) serovars, green urogenital (D–K) serovars, blue LGV/proctitis (L1–L3) serovars and yellow recombinant (in vitro) 
isolates. Except for the recombinant isolates, which have genomes consisting of a mixture of genomes from multiple C. trachomatis strains from dif-
ferent serovars in addition to foreign genetic elements from other species, the pathogroups cluster perfectly together. A slight, but marked, division 
can also be observed within the urogenital C. trachomatis serovars (green)
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linear. The incorporation of the average SNP AT con-
tent differences between the pathogroups to the average 
AT content of the genomes in serovars D–K and L1–L3, 
together with the average AT content of the correspond-
ing genetic fragments found in serovars D–K and A–C, 
resulted in slightly higher estimates of genomic AT 
content in serovars L1–L3 and D–K than observed in 
serovars D–K/A–C. As can be seen from Table 4 the dif-
ferences are small for each of the pathogroups and this 
could well be explained by lack of amelioration [19] and/
or the widespread recombination reported in the uro-
genital- and ocular clades [12, 16, 20, 21]. Indeed, recom-
bination within the urogenital biovar (including both T1 
and T2 clades, as shown in Fig. 1) may have occurred for 
as much as 30–40  % of the C. trachomatis genome [16, 
22]. Thus, the discrepancies between AT content and 
genome size not accounted for by the genomic fragments 
unique to the trachoma- and urogenital strains, in addi-
tion to differences in SNP AT content, are attributed to 
recombination events.
Discussion
Evolutionary analyses of the C. trachomatis strains
Compelling evidence has been put forth that there 
has been an early split in C. trachomatis from the LGV 
strains and the urogenital strains into two distinct clades, 
or biovars [12]. Figure  1 indicates that the passing of 
this coalescent event must be one of the earliest known 
occurrences of a split within C. trachomatis. Within the 
LGV clade there has been recorded only sporadic re-
combination events and even fewer such events between 
the LGV and urogenital strains [16, 22]. Hence, the 
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Fig. 3 Size versus AT content in all C. trachomatis strains. The left panel shows the genomic fraction of AT content (horizontal axis) in 79 C. tra-
chomatis genomes, colored according to pathogroup, regressed against genome size in mb (vertical axis), together with the estimated regression 
coefficient (black line). The right panel shows a close up of the left panel with the 12 recombinant in vitro strains removed. The dotted line, colored 
according to pathogroup, represent the estimated regression coefficients for each pathogroup
Table 1 Average genome size and AT content in the different pathogroups
Pathogroup Number of strains Average genome  
size (mb) (±95 % CI)
Average AT content  
(±95 % CI)
Ocular strains 9 1.0441 (1.0439–1.0444) 0.586987 (0.586966–0.587008)
Urogenital strains 36 1.0428 (1.0425–1.0432) 0.586941 (0.586923–0.586959)
LGV strains 22 1.0388 (1.0387–1.0389) 0.586746 (0.586723–0.586769)
Laboratory isolates 12 1.0529 (1.0407–1.0651) 0.586163 (0.585589–0.586718)
All 79 genomes 79 1.0434 (1.0415–1.0453) 0.586772 (0.586675–0.586870)
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Fig. 4 ACT comparison of one strain from each pathogroup. The figure shows an ACT comparison between C. trachomatis A/HAR 13 (top), C. 
trachomatis D/UW-3/CX (middle) and C. trachomatis L2b UCH1 (bottom). The figures also show designated genes for all strains as well as genomic 
positions. The red regions indicate presence of genetic regions in all genomes, while the white regions designate absence of genetic regions in one 
or more of the genomes
Table 2 Genes and proteins unique to the urogenital biovar
Gene fragment in serovars DNA sequence Protein sequence
Serovar A–C Part of cytotoxin gene (AY647992.1) Putative cytoadherence factor (CAX09718.1)
DUF3491 (pfam11996)
Serovar A–C/D–K Cytotoxic genes (homologous to AY647998.1) TcdA/TcdB catalytic glycosyltransferase domain (pfam12919)
TcdB toxin N-terminal helical domain (pfam12918)
DUF3491 superfamily (pfam11996)
Table 3 Average size and AT content of fragments unique to pathogroups
Pathogroup Isolates# Average size (bp) (95 % CI) Average AT content (95 % CI)
Genetic region not found in LGV strains 9 5789.7 (5753–5824.3) 0.601663 (0.600759–0.602566)
Genetic region exclusive to the ocular strains 9 1676.1 (1675.9–1676.4) 0.586357 (0.586357–0.586730)
Genetic region found in both ocular and urogenital strains 36 4445.9 (4443.3–4448.6) 0.609864 (0.609641–0.610087)
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LGV clade has, at least until now, been largely isolated 
from the urogenital strains [16, 23]. Within the urogeni-
tal strains however, several splitting events have taken 
place, in addition to numerous recombination events 
[12, 16, 22]. The earliest splitting within the urogenital 
clade seems to have resulted in two new minor clades 
(T1 and T2) both comprising predominantly urogenital 
strains [12, 22, 23]. Figure 3 shows a distinct size differ-
ence between the C. trachomatis A–C serovars and the 
urogenital pathogroup, suggesting an even more recent 
split within the urogenital T2 clade into the ocular patho-
group. That the strains from the A–C serovars have had 
a recent common ancestor with the T2 clade can be seen 
from the SNP based phylogenetic tree in Fig. 1 as well as 
in numerous studies [12, 16, 23]. That the ocular strains 
have emerged only once from the T2 clade, as suggested 
by Harris et al. [12] seems therefore to be supported by 
the approximately 1670  bp genetic fragment predomi-
nantly found within the A–C serovars. Interestingly, this 
genetic fragment was found to be GC-rich and increased 
GC content in genes has recently been associated with 
increased fitness [24, 25].
The LGV strains do not appear to have undergone any 
further major splits, and the strains’ genomes seem to be 
more homogeneous genome-wise than the strains within 
the urogenital clades [12].
The last common ancestor of the LGV‑ and urogenital 
strains
Due to the genome-wise homogeneity within the LGV 
clade it is tempting to speculate that these strains are 
more similar to the last common ancestor of both the 
LGV and urogenital strains. Within the urogenital clade 
however, there is wide-spread recombination [12, 16, 
22, 23] indicating far more genomic plasticity than what 
has been shown for the LGV clade [16, 22]. Horizontal 
transfer of DNA from distantly related bacteria to C. 
trachomatis does not seem to have taken place, at least 
not to a large extent. Indeed, the pan- and core genomes 
of the C. trachomatis strains have been found to be of 
similar size suggesting that genetic exchange takes place 
mostly within the same species [16]. In fact, as was noted 
above, genetic exchange appears to predominantly occur 
within the same biovar [12], which suggests that the 
strains within the urogenital clade have changed consid-
erably more genome-wise with respect to the last com-
mon ancestor of both urogenital- and LGV clades.
Analyses of C. trachomatis SNP AT content
From Fig.  5 it can be observed that the SNPs from the 
ocular strains are more AT rich than those from the uro-
genital strains, which in turn are more AT rich than those 
from the LGV strains. The largest difference detected in 
SNP AT content between the three lineages is within the 
ocular strains. This could mean that the split from the 
T2 clade mentioned above may be a consequence of a 
shift in environmental conditions leading to a substantial 
increase in genetic drift and/or a considerable reduction 
in population size [2]. In this regard it is interesting to 
recall the fact that the 23,942 SNPs identified genome-
wide for all 79 C. trachomatis genomes were slightly 
GC rich (see Fig.  5). The GC-richness of the SNPs may 
Table 4 AT content estimation of serovars A–C/D–K
Estimated average AT content (95 % CI) for Serovars L1–L3 and D–K after the inclusion of genetic fragment average AT content (95 % CI) unique to Serovars A–C and/
or D–K (column 2), as described in column 1. In column 3, average SNP AT content differences (95 % CI) between the pathogroups are included to the estimates in 
column 2. Column 4 describes average AT content (95 % CI) for all nine strains in Serovars A–C (top and bottom row) and the 22 strains in Serovars D–K (middle row)
Genomic fragment + serovar Estimated AT content from fragments Estimated AT content + SNP AT Observed average AT content
Sr L1-L3 + fragment Sr A–C 0.5868286 (0.5868004–0.586857) 0.5871145 (0.5870662–0.587163) 0.586987 (0.586966–0.587008)
Sr L1-L3 + fragment Sr D–K 0.5868445 (0.5868206–0.5868684) 0.5869537 (0.5869141–0.5869932) 0.586941 (0.586923–0.586959)
Sr D-K + fragment Sr A–C 0.586940 (0.5869221–0.5869586) 0.5871161 (0.587082–0.5871508) 0.586987 (0.586966–0.587008)
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Fig. 5 SNP AT content versus pathogroup. The box plot shows the 
AT content from 23,492 SNPs (vertical axis) in the LGV- (22), urogenital 
(36) and ocular strains (9), as well as for the laboratory isolates (12)
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indicate that C. trachomatis is, in general, subjected to 
selective constraints [24–26]. Since increased GC content 
has been associated with intensified selective pressures 
[24, 25] the larger genome size of the progressively more 
AT rich genomes of the urogenital- and ocular strains, 
respectively, could indicate that the increase in genome 
size in these strains are in fact a consequence of reduced 
selective constraints that allowed the strains to incorpo-
rate the genetic fragments [27]. Or, alternatively, the split 
into urogenital- and ocular pathogroups is so recent that 
the consequences of relaxed selective pressure has not 
started to result in reduced genome sizes. Nevertheless, 
the substantial increase in SNP AT richness for the ocu-
lar strains may support a recent dramatic split from the 
T2 clade [12].
C. trachomatis genome size and genomic fragments 
unique to the urogenital clade
Genome size in C. trachomatis was found to correlate 
with genomic AT content. A more detailed investiga-
tion, as can be seen in Fig. 3, revealed that the correlation 
between genome size and AT content was linked to the 
different pathogroups (excluding the artificially manipu-
lated laboratory isolates). The correlation between AT 
content and genome size in the C. trachomatis patho-
groups was largely explained by the genome size and the 
AT content of the genetic fragments unique to serovars 
A–C and D–K (see Table  4). On average, however, the 
addition of AT content from these genetic fragments 
to the genomic AT content of the LGV- and urogenital 
pathogroups resulted in slightly less AT rich genomes 
than what was observed from the strains incorporat-
ing these fragments. The average AT content differences 
between the pathogroups from the 23492 SNPs were 
therefore also incorporated into the AT content esti-
mates of the pathogroups lacking the genetic fragments 
unique to servars A–C/D–K. This resulted in slightly 
more AT rich pathogroups on the whole suggesting that 
both mutational biases, as described by the SNPs, as well 
as the incorporation of the genetic fragments unique to 
the urogenital- and ocular pathogroups explained the 
correlation between genome size and AT content in C. 
trachomatis. The lack of correlation between AT content 
and genome size within the LGV- and urogenital lineages 
appears therefore to be explained by, first and foremost, 
the absence of the genetic fragments. The difference in 
AT content within all three lineages, as can be observed 
from both Figs.  3, 5, seems to be described by smaller 
recombination events and mutational biases [21, 22]. The 
genetic fragments, or lack thereof, as in the case of the 
LGV strains, have previously been linked to symptoms 
particular to each pathogroup, i.e. urogenital infections 
(serovar D–K) and trachoma (serovars A–C) [20, 23, 28].
The origins of the genetic fragments unique within the C. 
trachomatis urogenital biovar
The genetic fragments particular to the trachoma and 
urogenital strains discussed here are widely present in 
other Chlamydia-species known to infect other animals 
[8, 9, 14, 15]. Since the genetic fragments unique to the 
urogenital and/or oculars strains, described in the pre-
sent work, are present in several other Chlamydia species 
a natural question is why they are not present in the LGV 
strains (and some only partly in the urogenital strains). 
One possibility is that the human infecting urogenital 
and LGV strains have undergone genome reduction from 
a common ancestor with the ocular strains. Since all the 
genetic fragments present in the ocular and urogenital 
strains are extant in several other Chlamydia species it 
is conceivable that they have been lost and re-gained in 
the C. trachomatis strains. However, this is difficult to 
document and if so this cannot have occurred in recent 
times since a BLAST search [29] with the genetic frag-
ments unique to C. trachomatis ocular- and urogenital 
strains were found to have a base composition substan-
tially different to that found in the other Chlamydia spe-
cies [8, 9]. It is also at odds with recent genomic research 
on C. trachomatis, which provide compelling evidence 
that the urogenital and LGV biovars shared a last com-
mon ancestor [12, 16]. Hence, a more plausible scenario 
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Fig. 6 SNP AT content versus genome size. The graph shows a gen-
eralized additive model (GAM) with genome size in 67 C. trachomatis 
genomes as the transformed response (vertical axis) and SNP AT con-
tent, estimated using a spline, as the explanatory variable (horizontal 
axis). The genomes are colored according to pathogroup: red ocular 
strains, green urogenital strains and blue LGV strains
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is that the genetic fragments exclusive to serovars A-C 
and the urogenital strains have been attained due to 
more recent recombination. This could indicate that the 
genetic fragments found only in the urogenital- and ocu-
lar pathogroups are present in other yet to be discovered 
C. trachomatis strains. Indeed, in Figs.  3, 5 one outlier 
from the urogenital lineage can be observed. This outlier 
was identified as C. trachomatis E SotoenE8. The strain 
appears to have a duplicated region in the plasticity zone 
[17] (approximate genomic position: 190,300–195,300, 
found to contain the proteins: PhnP, GloB, AlsT with 
the additional protein domains identified: SET, ABC_
ATPase, PEBP_bact_arch, Ftsk_gamma) also present 
in the other urogenital strains. Interestingly, the same 
genetic fraction consisting of approximately 1670 nucleo-
tides predominantly found in the ocular strains was also 
present in this urogenital strain. Yet, based on whole 
genome SNPs, the C. trachomatis E SotoenE8 strain clus-
ter with the urogenital T1 lineage (see Fig. 1). This may 
indicate that the genetic fragment predominantly found 
in the A–C serovars is also available for the D–K serovars 
suggesting that the acquisition of this genetic fragment 
may not alone sufficiently explain the splitting of the T2 
clade into the ocular pathogroup.
DNA uptake in Chlamydia sp.
An example of DNA uptake in Chlamydia sp. was 
observed in the previously described pig pathogen C. 
suis which has been found to carry a GI with antibiotic 
resistance genes [8]. It is believed that C. suis may have 
picked up the GI as a consequence of co-infection with 
the γ-proteobacterium Aeromonas salmonicida and the 
ε-proteobacterium Helicobacter pylori [15]. Although 
many co-infecting bacteria may not be directly patho-
genic to their hosts the case of C. suis shows that they 
can provide genes conferring resistance to tetracyclines, 
even though they belong to different phyla and have very 
different base compositions (The average AT content 
of A. salmonicida is ~41.5 %, compared to ~58 % for C. 
suis) [14]. The C. trachomatis laboratory isolates, men-
tioned previously, shows that gene transfer can take place 
between C. trachomatis and distantly related bacteria as 
well and therefore that the human pathogen can poten-
tially be an even more serious threat to public health; not 
only in developing countries but also in developed coun-
tries as well since C. trachomatis infections are, in gen-
eral, treated with tetracycline-based antibiotics [15, 28].
Conclusion
The correlation between genome size and AT content 
in C. trachomatis cannot be explained by the incorpo-
ration of AT-rich genetic fragments alone. Additionally 
accounting for SNP AT content differences, however, 
largely resolves the differences in AT content observed 
between the pathogroups. Whether the association 
between SNP AT content and genome size is due to 
relaxed selective forces remains to be identified.
Methods
All genomes were downloaded from NCBI/GenBank: 
http://www.ncbi.nlm.nih.gov/genome [30]. Additional 
file 1 contains all NCBI accession numbers. The genomes 
of the strains: C. trachomatis L2b Canada2 (NC020932), 
C. trachomatis E 12 94 (NC022108) and C. trachomatis 
J 27 97 (NC022110) were removed because of sequence 
errors. Genomic AT content and genome size were cal-
culated using in-house scripts. The heatmap in Fig.  2 is 
based on whole-genomic trinucleotide frequencies for 
each genome normalized by the respective genome’s 
nucleotide frequencies:
 fi designates the genomic frequencies of overlapping tri-
nucleotides XYZ or nucleotides X, Y or Z for genome i. 
Hierarchical cluster analysis, based on average linkage 
and Euclidean distance, was carried out on all possible 
combinations of trinucleotides (64 in total) for each of 79 
C. trachomatis genomes [11]. MAUVE [31] was used to 
identify SNPs for all C. trachomatis genomes and the for-
eign genetic regions were identified using MAUVE and 
the Artemis Comparison Tool (ACT) [18]. BLAST [29, 
30] was used on the NCBI “nr”-database [30] to extract 
the genomic fragments from all C. trachomatis strains 
as well as to search other Chlamydia sp. for these frag-
ments. BLAST was also used to prepare the genomes of 
C. trachomatis A/HAR 13 (NC 007429.1), C. trachoma-
tis D/UW-3/CX (NC 000117.1) and C. trachomatis L2b 
UCH1 (NC 010280.2) for ACT. The SNP-based phyloge-
netic tree was based on maximum likelihood estimation 
using the MEGA 6 software package [32], while the opti-
mal nucleotide substitution matrix was determined using 
the “ape” package in R [33]. The nucleotide substitution 
matrix obtaining the lowest AIC score [34] was GTR 
I + G, which was subsequently used in MEGA 6 for the 
construction of the maximum likelihood-based phyloge-
netic tree. The SNP sequences were aligned with MAFFT 
using automatic settings (selecting “rough alignment”) 
[35].
Due to few samples, outliers and indications of hetero-
scedasticity, correlation/association between genomic 
AT content and genome size was performed using “MM” 
type regression [36], from the “robust” package in R, 
for increased reliability. For the same reasons, statisti-
cal comparisons between pathogroups and genome size 
was performed using a modified version of Tukey’s test 
fi(XYZ)
fi(X)fi(Y )fi(Z)
.
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with the method described by Hothorn et  al. [37], and 
implemented in the R package “multcomp”, incorporating 
the vcovHC3 sandwich estimator [38] to compensate for 
the heteroscedastic variance. The average values found 
in Tables 1, 2 and 4 were computed using Welch’s t test 
with 95 % confidence intervals (95 % CI). The non-linear 
association observed between SNP AT content in the 79 
C. trachomatis genomes and genome size was modeled 
using a spline-based generalized additive model (GAM) 
[39] with genome size as the response variable and AT 
content as the explanatory variable. Details regarding 
the statistical estimations can be found in Additional 
file 2. The estimation of AT content change in the LGV 
and urogenital pathogroups was calculated by adding the 
average AT content of the genetic fragment to the aver-
age AT content of the genomes in the pathogroups of 
which the genetic fragments were missing and divide by 
the total number of nucleotides (i.e. average genome size 
of the genetic fragments in question and C. trachomatis 
genomes, respectively). The smallest and largest genome 
sizes as well as the highest and lowest AT content were 
calculated to produce the minimum/maximum intervals 
for both genome fragment and genome-wide AT content 
and genome size. An analogous procedure was carried 
out to account for AT content differences due to SNPs 
between the pathogroups; the 23492 SNPs were divided 
by the corresponding average pathogroup genome size 
and multiplied by the difference in SNP AT content 
between the pathogroups. The resulting estimates were 
added to the above-mentioned calculations regarding the 
genetic fractions unique to the A–C/D–K serovars. All 
statistical assessments were carried out in R [40].
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